Multiple sessions magnetic fluid hyperthermia: a requisite for apoptosis in prostate cancer cells LNCaP
Biomedical Materials · 2026
DOI: 10.1088/1748-605x/ae30be ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Materials, 2026. Verfasst von Uma Iyer und 3 weiteren Autor:innen. Beteiligte Einrichtung: P D Patel Institute of Applied Sciences, Charotar University of Science and Technology (CHARUSAT), Changa 388421, India. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Apoptosis, Hyperthermia, Induced. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
Magnetic fluid hyperthermia (MFH) is emerging as a promising cancer therapeutic modality due to its minimal side effects and targeted approach. This study presents the synthesis and characterization of temperature-sensitive biocompatible MF containing citric acid-coated Mn 0.9 Zn 0.1 Fe 2 O 4 nanoparticles, along with in vitro investigations on the prostate cancer cells LNCaP, to demonstrate the potential of these nanoparticles as a hyperthermic agent for MFH. The biocompatibility of MF was assessed using the MTT assay, which demonstrated no cytotoxic effects at concentrations up to 3 mg ml −1 . Furthermore, rapid internalization of nanoparticles into LNCaP prostate cancer cells was observed within 10 min, as determined by a Prussian blue assay and quantified by inductively coupled plasma mass spectrometry. Upon exposure to an alternating magnetic field of 10 kA m −1 and 332 kHz frequency, the nanoparticles achieved the therapeutic temperature of 42 °C within 27 min, while sustaining a hyperthermic range of 42 °C–45 °C for one hour. Notably, three MFH treatment sessions were identified as requisite for the elimination of LNCaP cells. Apoptosis was detected using Hoechst-Propidium iodide (PI) staining and further quantified by Annexin-V/PI flow cytometry. These findings underscore the potential of citric acid-coated Mn–Zn ferrite nanoparticles as effective biocompatible agents for MFH-based cancer therapy, warranting further detailed investigations to elucidate their therapeutic efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- P D Patel Institute of Applied Sciences, Charotar University of Science and Technology (CHARUSAT), Changa 388421, India.
- Dr. K C Patel Research and Development Centre, University Research Centre(s), Charotar University of Science and Technology (CHARUSAT), Changa 388421, India.
ORCID-Profile: Uma Iyer, Kinnari Parekh, Neeraj Jain
Zitieren
APA
Iyer, U., Patel, H., Parekh, K., & Jain, N. (2026). Multiple sessions magnetic fluid hyperthermia: a requisite for apoptosis in prostate cancer cells LNCaP. Biomedical Materials. https://doi.org/10.1088/1748-605x/ae30be
Vancouver
Iyer U, Patel H, Parekh K, Jain N. Multiple sessions magnetic fluid hyperthermia: a requisite for apoptosis in prostate cancer cells LNCaP. Biomedical Materials. 2026. doi:10.1088/1748-605x/ae30be
BibTeX
@article{Iyer2026,
author = {Iyer, Uma and Patel, Hima and Parekh, Kinnari and Jain, Neeraj},
title = {Multiple sessions magnetic fluid hyperthermia: a requisite for apoptosis in prostate cancer cells LNCaP},
journal = {Biomedical Materials},
year = {2026},
doi = {10.1088/1748-605x/ae30be}
}
EUVIMED